| Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. | |
| | |
MedLine Citation:
|
PMID: 20032117 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tubular epithelial cells secrete connective tissue growth factor (CTGF, CCN2), which contributes to tubulointerstitial fibrosis. However, the molecular regulation of CTGF in human primary tubular epithelial cells (hPTECs) is not well defined. Therefore, CTGF expression was characterized in hPTECs isolated from healthy parts of tumor nephrectomies, with special emphasis on the regulation by transforming growth factor-beta (TGF-beta) and hypoxia, essential factors in the development of fibrosis. CTGF synthesis was strongly dependent on cell density. High CTGF levels were detected in sparse cells, whereas CTGF expression was reduced in confluent cells. Concomitantly, stimulation of CTGF by TGF-beta or the histone deacetylase inhibitor trichostatin was prevented in dense cells. Exposure of hPTECs to low oxygen tension (1% O2) or the hypoxia mimetic dimethyl-oxalylglycine for 24 h reduced CTGF gene expression in most of the 17 preparations analyzed. Preincubation of the cells under hypoxic conditions significantly reduced TGF-beta-mediated upregulation of CTGF. In line with these data, CTGF mRNA was only induced in interstitial cells, but not in tubular cells in kidneys of mice exposed to hypoxia. Longer exposure to hypoxia or TGF-beta (up to 72 h) did not induce hPTECs to adopt a mesenchymal phenotype characterized by upregulation of alpha-smooth muscle actin, downregulation of E-cadherin, or increased sensitivity of the cells in terms of CTGF expression. Sensitivity was restored by inhibition of DNA methylation. Taken together, our data provide evidence that exposure to hypoxia decreased CTGF gene expression. Furthermore, hypoxia per se was not sufficient to induce a mesenchymal phenotype in primary tubular epithelial cells. |
| | |
Authors:
|
Sven Kroening; Emily Neubauer; Bernd Wullich; Jan Aten; Margarete Goppelt-Struebe |
Related Documents
:
|
15003627 - Loss of pgc-specific expression of the orphan nuclear receptor err-beta results in redu... 9628587 - Drp, a novel protein expressed at high cell density but not during growth arrest. 16448797 - A rapid chromogenic microtitre assay of arginine aminopeptidase activity in mycoplasma ... 9165297 - Lipid peroxidation in photodynamically stressed mammalian cells: use of cholesterol hyd... 2445917 - Depolarization-induced increase in surface binding and internalization of 125i-nerve gr... 6354297 - Alterations in the components of ribonucleotide reductase in hydroxyurea-resistant hams... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-12-23 |
Journal Detail:
|
Title: American journal of physiology. Renal physiology Volume: 298 ISSN: 1522-1466 ISO Abbreviation: Am. J. Physiol. Renal Physiol. Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-02-25 Completed Date: 2010-03-19 Revised Date: 2011-04-28 |
Medline Journal Info:
|
Nlm Unique ID: 100901990 Medline TA: Am J Physiol Renal Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: F796-806 Citation Subset: IM |
Affiliation:
|
Department of Nephrology and Hypertension, University Hospital of Erlangen-Nuremberg, Erlangen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acids, Dicarboxylic
/
pharmacology Cell Culture Techniques Cell Hypoxia Cell Proliferation Cells, Cultured Connective Tissue Growth Factor / genetics, metabolism* DNA Methylation DNA Modification Methylases / antagonists & inhibitors, metabolism Deoxyuridine / analogs & derivatives, pharmacology Enzyme Inhibitors / pharmacology Epithelial Cells / drug effects, metabolism* Histone Deacetylase Inhibitors / pharmacology Humans Hydroxamic Acids / pharmacology Kidney Tubules / drug effects, metabolism* Oxygen / metabolism Phenotype RNA, Messenger / metabolism Time Factors Transforming Growth Factor beta / metabolism Up-Regulation |
| Chemical | |
Reg. No./Substance:
|
0/Amino Acids, Dicarboxylic; 0/CTGF protein, human; 0/Enzyme Inhibitors; 0/Histone Deacetylase Inhibitors; 0/Hydroxamic Acids; 0/RNA, Messenger; 0/Transforming Growth Factor beta; 139568-91-5/Connective Tissue Growth Factor; 5262-39-5/oxalylglycine; 58880-19-6/trichostatin A; 7782-44-7/Oxygen; 951-78-0/Deoxyuridine; EC 2.1.1.-/DNA Modification Methylases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in exp...
Next Document: Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice.